[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Drugs for Osteoarthritis Pain Market Research Report 2017

May 2017 | 125 pages | ID: G7A52F2D331EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Drugs for Osteoarthritis Pain market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Drugs for Osteoarthritis Pain in these regions, from 2012 to 2022 (forecast), covering
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Global Drugs for Osteoarthritis Pain market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
  • Abbott Laboratories
  • Johnson & Johnson
  • Novartis International
  • Pfizer
  • AbbVie
  • Abiogen Pharma
  • Afferent Pharmaceuticals
  • Astellas Pharma
  • BioDelivery Sciences International
  • Crystal Genomics
  • Cytori Therapeutics
  • Daiichi Sankyo
  • Eli Lilly
  • Endo Pharmaceuticals Holdings
  • Horizon Pharma
  • iCeutica
  • Iroko Pharmaceuticals
  • Merck
  • Nuvo Research
  • Regeneron Pharmaceuticals
  • Sanofi
  • SantoSolve
  • Techfields Pharma
  • Winston Pharmaceuticals
  • Yooyoung Pharmaceutical
  • Zynerba Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Solid
  • Liquid
  • Semi-solid
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Drugs for Osteoarthritis Pain for each application, including
  • Oral
  • Injection
  • External
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Drugs for Osteoarthritis Pain Market Research Report 2017

1 DRUGS FOR OSTEOARTHRITIS PAIN MARKET OVERVIEW

1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Drugs for Osteoarthritis Pain Segment by Type (Product Category)
  1.2.1 Global Drugs for Osteoarthritis Pain Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
  1.2.2 Global Drugs for Osteoarthritis Pain Production Market Share by Type (Product Category) in 2016
  1.2.3 Solid
  1.2.4 Liquid
  1.2.5 Semi-solid
1.3 Global Drugs for Osteoarthritis Pain Segment by Application
  1.3.1 Drugs for Osteoarthritis Pain Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Oral
  1.3.3 Injection
  1.3.4 External
1.4 Global Drugs for Osteoarthritis Pain Market by Region (2012-2022)
  1.4.1 Global Drugs for Osteoarthritis Pain Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Drugs for Osteoarthritis Pain (2012-2022)
  1.5.1 Global Drugs for Osteoarthritis Pain Revenue Status and Outlook (2012-2022)
  1.5.2 Global Drugs for Osteoarthritis Pain Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN MARKET COMPETITION BY MANUFACTURERS

2.1 Global Drugs for Osteoarthritis Pain Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Drugs for Osteoarthritis Pain Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Drugs for Osteoarthritis Pain Production and Share by Manufacturers (2012-2017)
2.2 Global Drugs for Osteoarthritis Pain Revenue and Share by Manufacturers (2012-2017)
2.3 Global Drugs for Osteoarthritis Pain Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Drugs for Osteoarthritis Pain Manufacturing Base Distribution, Sales Area and Product Type
2.5 Drugs for Osteoarthritis Pain Market Competitive Situation and Trends
  2.5.1 Drugs for Osteoarthritis Pain Market Concentration Rate
  2.5.2 Drugs for Osteoarthritis Pain Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Drugs for Osteoarthritis Pain Capacity and Market Share by Region (2012-2017)
3.2 Global Drugs for Osteoarthritis Pain Production and Market Share by Region (2012-2017)
3.3 Global Drugs for Osteoarthritis Pain Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Drugs for Osteoarthritis Pain Consumption by Region (2012-2017)
4.2 North America Drugs for Osteoarthritis Pain Production, Consumption, Export, Import (2012-2017)
4.3 Europe Drugs for Osteoarthritis Pain Production, Consumption, Export, Import (2012-2017)
4.4 China Drugs for Osteoarthritis Pain Production, Consumption, Export, Import (2012-2017)
4.5 Japan Drugs for Osteoarthritis Pain Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Drugs for Osteoarthritis Pain Production, Consumption, Export, Import (2012-2017)
4.7 India Drugs for Osteoarthritis Pain Production, Consumption, Export, Import (2012-2017)

5 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Drugs for Osteoarthritis Pain Production and Market Share by Type (2012-2017)
5.2 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2012-2017)
5.3 Global Drugs for Osteoarthritis Pain Price by Type (2012-2017)
5.4 Global Drugs for Osteoarthritis Pain Production Growth by Type (2012-2017)

6 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN MARKET ANALYSIS BY APPLICATION

6.1 Global Drugs for Osteoarthritis Pain Consumption and Market Share by Application (2012-2017)
6.2 Global Drugs for Osteoarthritis Pain Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN MANUFACTURERS PROFILES/ANALYSIS

7.1 Abbott Laboratories
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Abbott Laboratories Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Johnson & Johnson
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Novartis International
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Novartis International Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Pfizer
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Pfizer Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 AbbVie
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 AbbVie Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Abiogen Pharma
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Abiogen Pharma Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Afferent Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Astellas Pharma
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Astellas Pharma Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 BioDelivery Sciences International
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 BioDelivery Sciences International Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Crystal Genomics
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Crystal Genomics Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Cytori Therapeutics
7.12 Daiichi Sankyo
7.13 Eli Lilly
7.14 Endo Pharmaceuticals Holdings
7.15 Horizon Pharma
7.16 iCeutica
7.17 Iroko Pharmaceuticals
7.18 Merck
7.19 Nuvo Research
7.20 Regeneron Pharmaceuticals
7.21 Sanofi
7.22 SantoSolve
7.23 Techfields Pharma
7.24 Winston Pharmaceuticals
7.25 Yooyoung Pharmaceutical
7.26 Zynerba Pharmaceuticals

8 DRUGS FOR OSTEOARTHRITIS PAIN MANUFACTURING COST ANALYSIS

8.1 Drugs for Osteoarthritis Pain Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Drugs for Osteoarthritis Pain Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN MARKET FORECAST (2017-2022)

12.1 Global Drugs for Osteoarthritis Pain Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Drugs for Osteoarthritis Pain Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Drugs for Osteoarthritis Pain Price and Trend Forecast (2017-2022)
12.2 Global Drugs for Osteoarthritis Pain Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Drugs for Osteoarthritis Pain Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Drugs for Osteoarthritis Pain Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Drugs for Osteoarthritis Pain Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Drugs for Osteoarthritis Pain Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Drugs for Osteoarthritis Pain Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Drugs for Osteoarthritis Pain Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Drugs for Osteoarthritis Pain Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Drugs for Osteoarthritis Pain Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Osteoarthritis Pain
Figure Global Drugs for Osteoarthritis Pain Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Drugs for Osteoarthritis Pain Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Solid
Table Major Manufacturers of Solid
Figure Product Picture of Liquid
Table Major Manufacturers of Liquid
Figure Product Picture of Semi-solid
Table Major Manufacturers of Semi-solid
Figure Global Drugs for Osteoarthritis Pain Consumption (K Pcs) by Applications (2012-2022)
Figure Global Drugs for Osteoarthritis Pain Consumption Market Share by Applications in 2016
Figure Oral Examples
Figure Injection Examples
Figure External Examples
Figure Global Drugs for Osteoarthritis Pain Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Drugs for Osteoarthritis Pain Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Drugs for Osteoarthritis Pain Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Drugs for Osteoarthritis Pain Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Drugs for Osteoarthritis Pain Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Drugs for Osteoarthritis Pain Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Drugs for Osteoarthritis Pain Major Players Product Production (K Pcs) (2012-2017)
Table Global Drugs for Osteoarthritis Pain Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Drugs for Osteoarthritis Pain Production Share by Manufacturers (2012-2017)
Figure 2016 Drugs for Osteoarthritis Pain Production Share by Manufacturers
Figure 2017 Drugs for Osteoarthritis Pain Production Share by Manufacturers
Figure Global Drugs for Osteoarthritis Pain Major Players Product Revenue (Million USD) (2012-2017)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Drugs for Osteoarthritis Pain Revenue Share by Manufacturers
Table 2017 Global Drugs for Osteoarthritis Pain Revenue Share by Manufacturers
Table Global Market Drugs for Osteoarthritis Pain Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Drugs for Osteoarthritis Pain Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Drugs for Osteoarthritis Pain Manufacturing Base Distribution and Sales Area
Table Manufacturers Drugs for Osteoarthritis Pain Product Category
Figure Drugs for Osteoarthritis Pain Market Share of Top 3 Manufacturers
Figure Drugs for Osteoarthritis Pain Market Share of Top 5 Manufacturers
Table Global Drugs for Osteoarthritis Pain Capacity (K Pcs) by Region (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Capacity Market Share by Region (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Capacity Market Share by Region (2012-2017)
Figure 2016 Global Drugs for Osteoarthritis Pain Capacity Market Share by Region
Table Global Drugs for Osteoarthritis Pain Production by Region (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Production (K Pcs) by Region (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Production Market Share by Region (2012-2017)
Figure 2016 Global Drugs for Osteoarthritis Pain Production Market Share by Region
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Region (2012-2017)
Table Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2012-2017)
Table 2016 Global Drugs for Osteoarthritis Pain Revenue Market Share by Region
Figure Global Drugs for Osteoarthritis Pain Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Drugs for Osteoarthritis Pain Consumption (K Pcs) Market by Region (2012-2017)
Table Global Drugs for Osteoarthritis Pain Consumption Market Share by Region (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Consumption Market Share by Region (2012-2017)
Figure 2016 Global Drugs for Osteoarthritis Pain Consumption (K Pcs) Market Share by Region
Table North America Drugs for Osteoarthritis Pain Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Drugs for Osteoarthritis Pain Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Drugs for Osteoarthritis Pain Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Drugs for Osteoarthritis Pain Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Drugs for Osteoarthritis Pain Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Drugs for Osteoarthritis Pain Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Drugs for Osteoarthritis Pain Production (K Pcs) by Type (2012-2017)
Table Global Drugs for Osteoarthritis Pain Production Share by Type (2012-2017)
Figure Production Market Share of Drugs for Osteoarthritis Pain by Type (2012-2017)
Figure 2016 Production Market Share of Drugs for Osteoarthritis Pain by Type
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Type (2012-2017)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Drugs for Osteoarthritis Pain by Type (2012-2017)
Figure 2016 Revenue Market Share of Drugs for Osteoarthritis Pain by Type
Table Global Drugs for Osteoarthritis Pain Price (USD/Pcs) by Type (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Production Growth by Type (2012-2017)
Table Global Drugs for Osteoarthritis Pain Consumption (K Pcs) by Application (2012-2017)
Table Global Drugs for Osteoarthritis Pain Consumption Market Share by Application (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Consumption Market Share by Applications (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Consumption Market Share by Application in 2016
Table Global Drugs for Osteoarthritis Pain Consumption Growth Rate by Application (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Consumption Growth Rate by Application (2012-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Production Growth Rate (2012-2017)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Production Market Share (2012-2017)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Drugs for Osteoarthritis Pain Production Growth Rate (2012-2017)
Figure Johnson & Johnson Drugs for Osteoarthritis Pain Production Market Share (2012-2017)
Figure Johnson & Johnson Drugs for Osteoarthritis Pain Revenue Market Share (2012-2017)
Table Novartis International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis International Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis International Drugs for Osteoarthritis Pain Production Growth Rate (2012-2017)
Figure Novartis International Drugs for Osteoarthritis Pain Production Market Share (2012-2017)
Figure Novartis International Drugs for Osteoarthritis Pain Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Drugs for Osteoarthritis Pain Production Growth Rate (2012-2017)
Figure Pfizer Drugs for Osteoarthritis Pain Production Market Share (2012-2017)
Figure Pfizer Drugs for Osteoarthritis Pain Revenue Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Drugs for Osteoarthritis Pain Production Growth Rate (2012-2017)
Figure AbbVie Drugs for Osteoarthritis Pain Production Market Share (2012-2017)
Figure AbbVie Drugs for Osteoarthritis Pain Revenue Market Share (2012-2017)
Table Abiogen Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abiogen Pharma Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abiogen Pharma Drugs for Osteoarthritis Pain Production Growth Rate (2012-2017)
Figure Abiogen Pharma Drugs for Osteoarthritis Pain Production Market Share (2012-2017)
Figure Abiogen Pharma Drugs for Osteoarthritis Pain Revenue Market Share (2012-2017)
Table Afferent Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Production Growth Rate (2012-2017)
Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Production Market Share (2012-2017)
Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Revenue Market Share (2012-2017)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Drugs for Osteoarthritis Pain Production Growth Rate (2012-2017)
Figure Astellas Pharma Drugs for Osteoarthritis Pain Production Market Share (2012-2017)
Figure Astellas Pharma Drugs for Osteoarthritis Pain Revenue Market Share (2012-2017)
Table BioDelivery Sciences International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Production Growth Rate (2012-2017)
Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Production Market Share (2012-2017)
Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Revenue Market Share (2012-2017)
Table Crystal Genomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Crystal Genomics Drugs for Osteoarthritis Pain Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Crystal Genomics Drugs for Osteoarthritis Pain Production Growth Rate (2012-2017)
Figure Crystal Genomics Drugs for Osteoarthritis Pain Production Market Share (2012-2017)
Figure Crystal Genomics Drugs for Osteoarthritis Pain Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Osteoarthritis Pain
Figure Manufacturing Process Analysis of Drugs for Osteoarthritis Pain
Figure Drugs for Osteoarthritis Pain Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2016
Table Major Buyers of Drugs for Osteoarthritis Pain
Table Distributors/Traders List
Figure Global Drugs for Osteoarthritis Pain Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Price (Million USD) and Trend Forecast (2017-2022)
Table Global Drugs for Osteoarthritis Pain Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Production Market Share Forecast by Region (2017-2022)
Table Global Drugs for Osteoarthritis Pain Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Consumption Market Share Forecast by Region (2017-2022)
Figure North America Drugs for Osteoarthritis Pain Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Drugs for Osteoarthritis Pain Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Drugs for Osteoarthritis Pain Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Drugs for Osteoarthritis Pain Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Drugs for Osteoarthritis Pain Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Drugs for Osteoarthritis Pain Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Drugs for Osteoarthritis Pain Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Drugs for Osteoarthritis Pain Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Drugs for Osteoarthritis Pain Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Drugs for Osteoarthritis Pain Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Drugs for Osteoarthritis Pain Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Drugs for Osteoarthritis Pain Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Drugs for Osteoarthritis Pain Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Production (K Pcs) Forecast by Type (2017-2022)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Type (2017-2022)
Table Global Drugs for Osteoarthritis Pain Price Forecast by Type (2017-2022)
Table Global Drugs for Osteoarthritis Pain Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

More Publications

Need Help?

Ask a Question

Market Reports

All Categories